This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Suzie Yoon, Principal at Ceteri Capital Some areas in healthcare are more exposed than others, but changes in policies and regulations generally play a significant role in healthcare funding, creating the framework in which healthcareinnovation can occur and providing guidance on how certain innovations can be funded and supported.
I spoke with David as part of my ongoing series of fireside chats with healthcareinnovation leaders – Harlow on Healthcare , on HealthcareNOW Radio. It is always a pleasure to speak with David Goldsmith ( @dsgold ), Chief Strategy Officer at WEGO Health. I, for one, hope that we don’t have to wait five years.
I spoke with David as part of my ongoing series of fireside chats with healthcareinnovation leaders – Harlow on Healthcare , on HealthcareNOW Radio. It is always a pleasure to speak with David Goldsmith ( @dsgold ), Chief Strategy Officer at WEGO Health. I, for one, hope that we don’t have to wait five years.
I spoke with David as part of my ongoing series of fireside chats with healthcareinnovation leaders – Harlow on Healthcare , on HealthcareNOW Radio. It is always a pleasure to speak with David Goldsmith ( @dsgold ), Chief Strategy Officer at WEGO Health. I, for one, hope that we don’t have to wait five years.
I spoke with David as part of my ongoing series of fireside chats with healthcareinnovation leaders – Harlow on Healthcare , on HealthcareNOW Radio. It is always a pleasure to speak with David Goldsmith ( @dsgold ), Chief Strategy Officer at WEGO Health. I, for one, hope that we don’t have to wait five years.
I spoke with David as part of my ongoing series of fireside chats with healthcareinnovation leaders – Harlow on Healthcare , on HealthcareNOW Radio. It is always a pleasure to speak with David Goldsmith ( @dsgold ), Chief Strategy Officer at WEGO Health. I, for one, hope that we don’t have to wait five years.
Aprima belongs to CommonWell, has done some FHIR development, and Michael would like to see Congress condition Medicare reimbursement on real interoperability. The goal is to compile the most complete patient profile possible, for the benefit of health plans, pharmacy, lifesciences, ACOs, providers.
Aprima belongs to CommonWell, has done some FHIR development, and Michael would like to see Congress condition Medicare reimbursement on real interoperability. The goal is to compile the most complete patient profile possible, for the benefit of health plans, pharmacy, lifesciences, ACOs, providers.
This year, the company announced an initiative, Healthcare NExT, to create products for medical providers and patients with the goal of accelerating healthcareinnovation using artificial intelligence and cloud services. Verily Verily, formerly Google LifeSciences, was founded in 2015.
Aprima belongs to CommonWell, has done some FHIR development, and Michael would like to see Congress condition Medicare reimbursement on real interoperability. The goal is to compile the most complete patient profile possible, for the benefit of health plans, pharmacy, lifesciences, ACOs, providers.
Aprima belongs to CommonWell, has done some FHIR development, and Michael would like to see Congress condition Medicare reimbursement on real interoperability. The goal is to compile the most complete patient profile possible, for the benefit of health plans, pharmacy, lifesciences, ACOs, providers.
Aprima belongs to CommonWell, has done some FHIR development, and Michael would like to see Congress condition Medicare reimbursement on real interoperability. The goal is to compile the most complete patient profile possible, for the benefit of health plans, pharmacy, lifesciences, ACOs, providers.
There is huge potential to use this data to impact health care, lifesciences, discovery, treatment, and every point along the continuum to transform patients’ lives. Those two trends have existed in a false dichotomy where healthcare organizations are either looking at population-level metrics (e.g.,
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content